NASDAQ:OMDA
Omada Health, Inc.
Omada Health, Inc.'s revenue grew 53.2% in fiscal 2025 to $260.2M while operating margin rose to −4.6%, its highest in 3 years. Free cash flow was $16.9M, 6.5% of revenue, and the diluted share count rose 374.5%.Summary generated from Omada Health, Inc.'s SEC filings. Latest annual report filed Mar 6, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$260.2M
Revenue growth+53.2%
Revenue, 5-yr CAGRn/a
Gross margin65.7%
Operating margin−4.6%
Net margin−4.9%
ROICn/a
Return on equityn/a
Debt / equity0.00
Free cash flow$16.9M
FCF margin6.5%
Share count change+374.5%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 123 | 170 | 260 |
| Operating income | −66 | −44 | −12 |
| Net income | −68 | −47 | −13 |
| Free cash flow | −50 | −35 | 17 |
Recent filings
- 4Insider transaction report
Oct 7, 2026 - 4Insider transaction report
Oct 7, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KResults of a shareholder vote
Jun 16, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 8, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - DEF 14AProxy statement
Apr 28, 2026